Population
patients with native mitral regurgitation
Design
Review
Authors
Loading...
Clinicians should await further data before adopting transcatheter mitral technologies; leaves open their role pending rigorous efficacy and safety trials.
Transcatheter mitral therapies offer a potentially exciting new strategy for treating severe mitral regurgitation, though further clinical studies are required to establish efficacy, safety, and patient selection.
Sorajja et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: